// App-Quantinova.ai

3164 : Molecular determination of the clonal relationship between multiple tumors in BRCA1/2-associated cancer patients has clinical relevance

Researchers

Presenter

  • Willemina R.R. Geurts-Giele

Principal Investigators

  • Victorien M.T. van Verschuer

  • Carolien H.M. van Deurzen

  • Paul J. van Diest

  • Rute M. Pedrosa

  • J. Margriet Collee

  • Linetta B. Koppert

  • Caroline Seynaeve

  • Winand N.M. Dinjens

Medical Centers

  • Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

  • University Medical Center Utrecht, Utrecht, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Phosphatase and tensin homolog

  • Cyclin Dependent Kinase Inhibitor 2A

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A